Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingyan Liangsang is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Shaanxi Longhui Biological Pharmaceutical Co., Ltd. for the treatment of acute pharyngitis and related throat conditions. Typically administered as granules (Qingyan Liangsang Keli), the product is composed of a blend of herbal ingredients traditionally used to clear heat, resolve toxicity, and soothe the pharynx. Its pharmacological effects include reducing inflammation and congestion in the pharyngeal mucosa, thereby alleviating symptoms such as sore throat, hoarseness, and dryness. As a TCM drug, it is widely used in the Chinese market for upper respiratory symptom management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingyan Liangsang.